Israel stocks higher at close of trade; TA 35 up 0.60%

Investing.com – Israel stocks were higher after the close on Sunday, as gains in the , and sectors led shares higher.

At the close in Tel Aviv, the rose 0.60% to hit a new 52-week high.

The best performers of the session on the were Liveperson (TASE:), which rose 6.73% or 840 points to trade at 13320 at the close. Meanwhile, Teva Pharmaceutical Industries Ltd (TASE:) added 5.73% or 192 points to end at 3542 and OPKO Health Inc (TASE:) was up 4.62% or 23 points to 521 in late trade.

The worst performers of the session were Azrieli Group Ltd (TASE:), which fell 2.57% or 690 points to trade at 26110 at the close. Nice Ltd (TASE:) declined 2.31% or 1270 points to end at 53790 and Tower Semiconductor Ltd (TASE:) was down 2.15% or 171 points to 7795.

Rising stocks outnumbered declining ones on the Tel Aviv Stock Exchange by 241 to 143 and 34 ended unchanged.

Crude oil for January delivery was unchanged 0.00% or 0.00 to $56.85 a barrel. Elsewhere in commodities trading, Brent oil for delivery in January rose 1.70% or 1.06 to hit $63.34 a barrel, while the December Gold Futures contract fell 0.32% or 4.65 to trade at $1468.75 a troy ounce.

USD/ILS was down 0.25% to 3.4732, while EUR/ILS rose 0.03% to 3.8386.

The US Dollar Index Futures was down 0.17% at 97.857.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.